Terms: = Prostate cancer AND MSH2, COCA1, 4436, ENSG00000095002, HNPCC, FCC1, HNPCC1, P43246 AND Treatment
40 results:
1. The impact of telomere length on prostate cancer aggressiveness, genomic instability and health disparities.
Huang R; Bornman MSR; Stricker PD; Simoni Brum I; Mutambirwa SBA; Jaratlerdsiri W; Hayes VM
Sci Rep; 2024 Apr; 14(1):7706. PubMed ID: 38565642
[TBL] [Abstract] [Full Text] [Related]
2. Identification of Genes with Rare Loss of Function Variants Associated with Aggressive prostate cancer and Survival.
Saunders EJ; Dadaev T; Brook MN; Wakerell S; Govindasami K; Rageevakumar R; Hussain N; Osborne A; Keating D; Lophatananon A; Muir KR; ; Darst BF; Conti DV; Haiman CA; Antoniou AC; Eeles RA; Kote-Jarai Z
Eur Urol Oncol; 2024 Apr; 7(2):248-257. PubMed ID: 38458890
[TBL] [Abstract] [Full Text] [Related]
3. Genomic characterization of IDH-mutant astrocytoma progression to grade 4 in the treatment setting.
Rautajoki KJ; Jaatinen S; Hartewig A; Tiihonen AM; Annala M; Salonen I; Valkonen M; Simola V; Vuorinen EM; Kivinen A; Rauhala MJ; Nurminen R; Maass KK; Lahtela SL; Jukkola A; Yli-Harja O; Helén P; Pajtler KW; Ruusuvuori P; Haapasalo J; Zhang W; Haapasalo H; Nykter M
Acta Neuropathol Commun; 2023 Nov; 11(1):176. PubMed ID: 37932833
[TBL] [Abstract] [Full Text] [Related]
4. Uncommon variants detected via hereditary cancer panel and suggestions for genetic counseling.
Özdemir Z; Çevik E; Öksüzoğlu ÖBÇ; Doğan M; Ateş Ö; Esin E; Bilgetekin İ; Demirci U; Köseoğlu Ç; Topal A; Karadurmuş N; Erdem HB; Bahsi T
Mutat Res; 2023; 827():111831. PubMed ID: 37453313
[TBL] [Abstract] [Full Text] [Related]
5. Mismatch repair gene germline mutations in patients with prostate cancer.
Fang B; Wei Y; Pan J; Zhang T; Ye D; Zhu Y
Zhejiang Da Xue Xue Bao Yi Xue Ban; 2023 Apr; 52(2):133-138. PubMed ID: 37283096
[TBL] [Abstract] [Full Text] [Related]
6. Genetic and Genomic Testing for prostate cancer: Beyond DNA Repair.
Herberts C; Wyatt AW; Nguyen PL; Cheng HH
Am Soc Clin Oncol Educ Book; 2023 May; 43():e390384. PubMed ID: 37207301
[TBL] [Abstract] [Full Text] [Related]
7. Germline genetics of prostate cancer.
Khan HM; Cheng HH
Prostate; 2022 Aug; 82 Suppl 1(Suppl 1):S3-S12. PubMed ID: 35657157
[TBL] [Abstract] [Full Text] [Related]
8. A case of microsatellite instability-high clinically advanced castration-resistant prostate cancer showing a remarkable response to pembrolizumab sustained over at least 18 months.
Shimizu K; Sano T; Mizuno K; Sunada T; Makita N; Hagimoto H; Goto T; Sawada A; Fujimoto M; Ichioka K; Ogawa O; Kobayashi T; Akamatsu S
Cold Spring Harb Mol Case Stud; 2022 Jun; 8(4):. PubMed ID: 35487690
[TBL] [Abstract] [Full Text] [Related]
9. Histopathological and genetic features of mismatch repair-deficient high-grade prostate cancer.
Wyvekens N; Tsai HK; Sholl LM; Tucci J; Giannico GA; Gordetsky JB; Hirsch MS; Barletta JA; Acosta AM
Histopathology; 2022 Jun; 80(7):1050-1060. PubMed ID: 35395112
[TBL] [Abstract] [Full Text] [Related]
10. A phase 2 trial of avelumab in men with aggressive-variant or neuroendocrine prostate cancer.
Brown LC; Halabi S; Somarelli JA; Humeniuk M; Wu Y; Oyekunle T; Howard L; Huang J; Anand M; Davies C; Patel P; Staats J; Weinhold KJ; Harrison MR; Zhang T; George DJ; Armstrong AJ
Prostate Cancer Prostatic Dis; 2022 Apr; 25(4):762-769. PubMed ID: 35292724
[TBL] [Abstract] [Full Text] [Related]
11. DNA-repair status should be assessed in treatment-emergent neuroendocrine prostate cancer before platinum-based therapy.
Zhu S; Zhang Z; Zhang H; Liu Z; Liu M; Liu Q; Zang L; Wang L; Ji J; Wu B; Sun L; Zhang Z; Cao H; Wang Y; Wang H; Shang Z; Niu Y
Prostate; 2022 Mar; 82(4):464-474. PubMed ID: 35037281
[TBL] [Abstract] [Full Text] [Related]
12. Inherited Mutations in Chinese Men With prostate cancer.
Zhu Y; Wei Y; Zeng H; Li Y; Ng CF; Zhou F; He C; Sun G; Ni Y; Chiu PKF; Teoh JYC; Wang B; Pan J; Wan F; Dai B; Qin X; Lin G; Gan H; Wu J; Ye D
J Natl Compr Canc Netw; 2021 Oct; 20(1):54-62. PubMed ID: 34653963
[TBL] [Abstract] [Full Text] [Related]
13. Genetically Informed prostate cancer treatment for Metastatic Disease.
Siebert AL; Szymaniak BM; Numan Y; Morgans AK
Urol Clin North Am; 2021 Aug; 48(3):365-371. PubMed ID: 34210491
[TBL] [Abstract] [Full Text] [Related]
14. Double heterozygotes of BRCA1/BRCA2 and mismatch repair gene pathogenic variants: case series and clinical implications.
Laish I; Friedman E; Levi-Reznick G; Kedar I; Katz L; Levi Z; Halpern N; Parnasa S; Abu-Shatya A; Half E; Goldberg Y
Breast Cancer Res Treat; 2021 Aug; 188(3):685-694. PubMed ID: 34086170
[TBL] [Abstract] [Full Text] [Related]
15. Atorvastatin Enhances Inhibitory Effects of Irradiation on Tumor Growth by Reducing msh2 Expression Both in prostate cancer Cells and Xenograft Tumor Models.
He Z; Xu D; Shen F; Zeng F; Qi P; Zhai Z; Wang Z
Anticancer Agents Med Chem; 2022; 22(7):1328-1339. PubMed ID: 34080969
[TBL] [Abstract] [Full Text] [Related]
16. Unexpected tumor response to palliative pelvic radiotherapy in mismatch repair-deficient advanced prostate cancer: a case report.
Aluisio G; Mazzeo E; Lohr F; Fiocchi F; Bettelli S; Baldessari C; Paterlini M; Bruni A
J Med Case Rep; 2020 Dec; 14(1):239. PubMed ID: 33287897
[TBL] [Abstract] [Full Text] [Related]
17. Evaluation of a Mainstream Model of Genetic Testing for Men With prostate cancer.
Scheinberg T; Goodwin A; Ip E; Linton A; Mak B; Smith DP; Stockler MR; Strach MC; Tran B; Young AL; Zhang AY; Mahon KL; Horvath LG
JCO Oncol Pract; 2021 Feb; 17(2):e204-e216. PubMed ID: 32970524
[TBL] [Abstract] [Full Text] [Related]
18. Atorvastatin Enhances Effects of Radiotherapy on prostate cancer Cells and Xenograft Tumor Mice Through Triggering Interaction Between Bcl-2 and msh2.
He Z; Yuan J; Shen F; Zeng F; Qi P; Wang Z; Zhai Z
Med Sci Monit; 2020 Sep; 26():e923560. PubMed ID: 32870824
[TBL] [Abstract] [Full Text] [Related]
19. Dianhydrogalactitol synergizes with topoisomerase poisons to overcome DNA repair activity in tumor cells.
Zhai B; Li Y; Kotapalli SS; Bacha J; Brown D; Steinø A; Daugaard M
Cell Death Dis; 2020 Jul; 11(7):577. PubMed ID: 32709853
[TBL] [Abstract] [Full Text] [Related]
20. Hereditary Predisposition to prostate cancer: From Genetics to Clinical Implications.
Brandão A; Paulo P; Teixeira MR
Int J Mol Sci; 2020 Jul; 21(14):. PubMed ID: 32708810
[TBL] [Abstract] [Full Text] [Related]
[Next]
